Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation: a prospective, randomized, multi-centre, open label trial.
第一作者:
Prapa,Kanagaratnam
第一单位:
National Heart and Lung Institute, Imperial College London, St Mary's Hospital, Praed Street, Paddington W2 1NY, UK.;Cardiology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, 72 Du Cane Rd, London, W12 0HS, UK.
作者:
主题词
人类(Humans);心房颤动(Atrial Fibrillation);抗心律失常药(Anti-Arrhythmia Agents);治疗结果(Treatment Outcome);前瞻性研究(Prospective Studies);医院(Hospitals);导管消融术(Catheter Ablation);肺静脉(Pulmonary Veins);复发(Recurrence)
DOI
10.1093/europace/euac253
PMID
36576323
发布时间
2023-05-08
- 浏览0

Europace
863-872页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文